The parenteral toxicity of clindamycin 2-phosphate in laboratory animals.
D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001835:Body Weight / Q000187:drug effects; D002981:Clindamycin / Q000494:pharmacology / Q000633:toxicity*; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006461:Hemolysis / Q000187:drug effects; D007249:Inflammation / Q000139:chemically induced; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007928:Lethal Dose 50; D008099:Liver / Q000166:cytology; D051379:Mice; D008854:Microscopy, Electron; D009132:Muscles / Q000187:drug effects; D010710:Phosphates / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013194:Staining and Labeling
D010710:Phosphates; D002981:Clindamycin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase